Author

Biography for Ryan McBride

Ryan McBride is an award-winning journalist who writes about the life sciences industry. Prior to joining FierceMarkets, he was a freelance journalist and served as a correspondent at Xconomy for more than two years. His stories have appeared in The Boston Globe, the Boston Business Journal, The Motley Fool, and many other publications. In recent years, he has also given guest lectures to graduate students at Boston University’s Center for Science & Medical Journalism. Earlier in his career, he held staff reporter positions at Mass High Tech, Providence Business News, and The Westerly Sun. Ryan enjoys spending time with his family and exploring mountains and beaches in New England. Follow Ryan on Twitter at @RyanMFierce or send him e-mail here.

Articles by Ryan McBride

Scripps scientists spot tropical disease marker in urine

Scientists found a molecular clue in their search for ways to wipe out one of the most devastating tropical diseases on earth. Known as river blindness, Onchocerciasis is a leading cause of vision loss, especially in the developing world. Yet the disease leaves behind a biomarker in the urine of patients that could easily identify those in need of treatment.

Protein doubles as diagnostic and drug target for blood cancer

Scientists have tied the activity of a life-supporting protein for cells to poor outcomes in patients with the blood cancer multiple myeloma, according to ScienceDaily. And their findings could aid clinicians in diagnosing patients while exposing a target for new therapies.

Supreme Court to tackle gene patent case

The U.S. Supreme Court is going to take up a case that could have a major impact on the patentability of genes used in diagnostics.

Biotech grabs $2M to discover biomarkers for personalized autism treatment

Seaside Therapeutics wants to home in on which autism patients are likely to respond to its lead drug, STX-209 (arbaclofen). The Cambridge, MA-based biotech won a $2 million award with funds from Autism Speaks, a major research funder and advocate for awareness of autism spectrum disorders (ASDs).

Suspected anti-Parkinson's gene spotted in 23andMe database

A genetic finding has triggered research that could lead to a new weapon against Parkinson's disease, a neurological disorder in dire need of new therapies. And the discovery has come from a somewhat

Experts back biomarker test to catch HGH users

The Associated Press reported this week that a new biomarker test that could spot evidence of human-growth hormone in the blood for up to 21 days has garnered support from experts and scientists

Scientists piecing together genetic puzzle in type 1 diabetes

Scientists have hunted down genetic markers implicated in type 1 diabetes, adding to a body of genetic evidence about the metabolic disorder that could explain disease risk and expose pathways for

Computers spot new markers linked to cardio death

Computers have proved people wrong again. What were pushed aside as "noises" in ECG data have now been identified--thanks to researchers' use of data-mining and machine learning methods--as

Alzheimer's indicator spikes after surgery

For years, people have talked about the potential of anesthesia being linked to Alzheimer's disease progression without any hard evidence to prove it. With advances in biomarker testing, a small

Mutated gene sheds light on blood cancers

When patients are suspected of having a blood-related disorder called myelodysplasia, which can lead to leukemia, doctors perform painful procedures to remove tissue from their bone marrow for